Table 1.
Reference | Total No. Patients (Events) |
No. Patients (Events) Included in Analysis |
Key characteristics | Adjuvant therapy |
---|---|---|---|---|
Wang et al | 286 (107) | 192 (73) | Node negative | None |
Van de Vijver et al |
295(101) | 212 (68) | Stage 1–II, < 53 years |
Chemotherapy (90), hormones (20), both (20), or none (165) |
Desmedt et al | 198 (91) | 124 (33) | Node negative | None |
Loi et al | 263 (87) | 224 (70) | Stage I–II, ER+ | Tamoxifen |